BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/17/2026 8:23:30 AM | Browse: 2 | Download: 0
 |
Received |
|
2025-11-17 02:33 |
|
Peer-Review Started |
|
2025-11-17 02:33 |
|
First Decision by Editorial Office Director |
|
2025-12-30 07:37 |
|
Return for Revision |
|
2025-12-30 07:37 |
|
Revised |
|
2025-12-30 09:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-29 02:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-29 07:20 |
|
Articles in Press |
|
2026-01-29 07:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-13 01:07 |
|
Publish the Manuscript Online |
|
2026-07-17 08:23 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Editorial |
| Article Title |
Small tumors, big decisions: Rethinking resection and ablation in early hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marcello Maestri and Ottavia Cicerone |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marcello Maestri, MD, PhD, Professor, General Surgery Unit I - Liver Service, Fondazione IRCCS Policlinico San Matteo, P.le Golgi 19, Pavia 27100, Italy. m.maestri@smatteo.pv.it |
| Key Words |
Hepatocellular carcinoma; Liver resection; Radiofrequency ablation; Therapeutic hierarchy; Barcelona Clinic Liver Cancer; Local ablation |
| Core Tip |
Early hepatocellular carcinoma (HCC) is typically managed with resection or local ablation, yet growing evidence shows that resection provides superior long-term oncologic outcomes whenever feasible. Modern ablative technologies—no-touch RFA, microwave ablation, and fusion-imaging guidance—have improved local control but do not surpass the curative potential of anatomical resection. The limitations of the BCLC staging system highlight the need for individualized decision-making. The therapeutic hierarchy, ranking treatments by intrinsic curative power, offers a dynamic, patient-centered framework better aligned with contemporary practice. Selecting the highest feasible therapy for each patient ensures the best outcomes in early-stage HCC. |
| Publish Date |
2026-07-17 08:23 |
| Citation |
Maestri M, Cicerone O. Small tumors, big decisions: Rethinking resection and ablation in early hepatocellular carcinoma. World J Gastroenterol 2026; 32(29): 116653
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i29/116653.htm |
| DOI |
https://doi.org/10.3748/wjg.116653 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
